TRPC3 contributes to cyclophosphamide-induced cystitis progression by enhancing bladder fibrosis through activation of the TGF-β/smad pathway
BackgroundBladder pain syndrome/Interstitial cystitis (BPS/IC) is a chronic urological disorder affecting 2.7%–6.5% of the population. The condition is characterized by significant bladder-related pain, with approximately 50% of IC/BPS patients exhibiting bladder fibrosis. Transient receptor potenti...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1565156/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|